Revolutionizing Early Bladder Cancer Detection with Urine-Based Genomic Liquid Biopsies
Time: 1:40 pm
day: Day Two Track A (PM)
Details:
- Utilizing urine samples for patient screening, providing a reliable and patient-friendly alternative that addresses the challenges associated with tissue and plasma-based testing
- Employing a highly sensitive genomic method capable of identifying a broad spectrum of genetic alterations
- Leveraging the robust detection capabilities of urine-based assays to facilitate earlier diagnosis and more personalized treatment strategies
